NEW YORK, July 19, 2018 /CNW/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE: RDY). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/rdy.
The investigation concerns whether Dr. Reddy's and certain of its officers and/or directors have violated federal securities laws.
On June 15, 2018, the U.S. District Court for the District of New Jersey granted a request by Indivior PLC ("Indivior") for a temporary restraining order compelling Dr. Reddy's to cease its launch activities related to the Company's Suboxone Film product, pending resolution of Indivior's motion for a preliminary injunction to block the product's release. On July 13, 2018, the court granted Indivior's motion and entered a preliminary injunction order to that effect. On this news, the price of the American depositary receipts of Dr. Reddy's fell $3.46, or 10.41%, to close at $29.78 on July 16, 2018, the following trading day.
If you are aware of any facts relating to this investigation, or purchased Dr. Reddy's shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/rdy. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]
SOURCE Bronstein, Gewirtz & Grossman, LLC
Share this article